Tirzepatide For Weight Loss

Welcome to Dr. David Nazarian’s esteemed weight loss clinic in the heart of Los Angeles. If you’ve been tirelessly searching for a medically supervised, effective weight loss solution, you’ve just found your answer: Tirzepatide For Weight Loss.

Tirzepatide For Weight Loss - Weight Loss Clinic

Did you know? Tirzepatide has proven to be more effective than Semaglutide for weight loss. More on that later, but first, let’s understand what Tirzepatide is and why you need it.


At Weight Loss Clinic Los Angeles, we offer Tirzepatide injections such as Mounjaro and Zepbound. We can schedule you for a telehealth appointment with our physician or an in office visit and ship the best compounded Mounjaro to your door step. Our physician can perform a thorough examination of your health and consultation about your family and personal history and ensure that this treatment is right for you.  Contact us today to  schedule your consultation with us.


What is tirzepatide?


Tirzepatide (Mounjaro)  is a synthetically made drug used to treat type 2 diabetes. It is the first drug that is made from glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) agonist, which is used to treat type 2 diabetes mellitus as a single therapy or with other diabetes medicines [1]. It is still not approved for treating type-1 diabetes mellitus and has not been studied in patients with pancreatitis.

Is tirzepatide available for weight loss?


Yes. Tirzepatide can effectively be used for weight loss in obese adults. It decreases appetite and slows down food digestion and absorption, making you feel full more quickly and for a long time.


A study conducted with participants with obesity issues stated that treatment with Tirzepatide had an average weight loss of 10%-20% of their body weight after 72 weeks [2].


What class of drug is tirzepatide?


Tirzepatide is an incretin mimetic drug. It contains both GIP and GLP-1 hormones. And because Tirzepatide contains both the incretin hormones (stimulates beta cells in the pancreas to release insulin), they are called also called Twincretin [3].


What is tirzepatide’s brand name?


Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. It is marketed under the brand names Mounjaro and Zepbound.

How it works

Contact us at +1 424-283-4273 to schedule an in office consult or virtual consult

or Book Online to receive your prescription of Wegovy or other Semaglutide or Trizepatide for weight loss.

  • Virtual Consult with MD & Nutritionist $450
  • 3 Month Supply of the best compounded semaglutide injection  $750 ( Special Pricing) 
  • Follow Ups $250
  • Lose 10 – 20% of body fat safely and effectively
Dr. David Nazarian

How fast does tirzepatide weight loss work?


A study suggested that people who kept taking tirzepatide or Mounjaro for 72 weeks (a year and a half) lost 15% of their body weight on average. The duration depends on various pointers like age, gender, diet, lifestyle choice, etc.


How much does mounjaro cost?


According to Drugs.com, the cost for Tirzepatide subcutaneous solution (2.5 mg/0.5 mL) is around $1,135 for a supply of 2 milliliters. However, you can save on your prescription by using a savings card, a 90-day supply, or a manufacturer coupon.


Can I get trzepatide for weight loss?


Yes, tirzepatide is used for weight loss in adults with obesity or type 2 diabetes. You need to consult your doctor and get yourself examined first before considering tirzepatide. Patients with a personal or family history of thyroid cancer or a condition called Multiple Endocrine Neoplasia syndrome shouldn’t take tirzepatide. Also, if you have type 1 diabetes, you shouldn’t go for tirzepatide.


Who cannot take tirzepatide?


 You should not use Tirzepatide or Mounjaro if you are allergic to it, or if you have a personal or family history of medullary thyroid carcinoma (a type of thyroid cancer), or multiple endocrine neoplasia type 2 (tumors in your glands). Tirzepatide is an incretin mimetic drug and a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) receptor agonist 2


If you’re allergic to tirzepatide or you have a family history of thyroid cancer, it’s best to avoid taking tirzepatide. Patients with tumors in glands should also avoid taking tirzepatide.


Side effects of Mounjaro

  • Abdominal pain or discomfort
  • Constipation
  • Decreased appetite
  • Diarrhea
  • Nausea and vomiting

Side effects of Mounjaro - Weight Loss Clinic

More serious side effects include:

  • Acute gallbladder disease
  • Acute kidney injury
  • Hypoglycemia
  • Gastroparesis
  • Pancreatitis
  • Vision changes

Tirzapatide vs. Semaglutide


Tirzepatide and semaglutide are both type 2 diabetes drugs that are often used for weight management. While studies showed that tirzepatide is potentially more effective [4], it’s too early to get to a conclusion, and substantial research is needed. Both drugs can help you feel less hungry.


Tirzepatide (Mounjaro) contains glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) agonists. Tirzepatide mimics the GLP-1 hormone and the GIP hormone. The GIP hormone can also trigger insulin production and trigger your sense of fullness which could help in weight loss.

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist sold under brand names such as Ozempic, Wegovy, and Rybelsus. The FDA has approved Wegovy for managing weight.


How effective is Mounjaro for weight loss?


Clinical trials suggest that Mounjaro is somewhat effective in causing weight loss in people who take it. A study conducted by Eli Lilly amongst participants achieved a total average weight loss of 26.6% over 84 weeks.

Another Cleveland Clinic study showed that 2500 obese adults taking 5 mg of Mounjaro for 72 weeks lost 15% of their body weight [5].


Can I get tirzepatide without diabetes?


Yes, Tirzepatide can be used for weight loss in adults with obesity or type 2 diabetes.


How long can you take tirzepatide?


According to Mayo Clinic, the usual adult dose for Tirzepatide is 2.5 mg subcutaneously once a week for the first 4 weeks. After 4 weeks, the dosage should be increased to 5 mg subcutaneously once a week. For additional glycemic control, the dosage can be increased in 2.5 mg increments after at least 4 weeks on the current dose.


Is tirzepatide bad for the kidneys?


A study concluded that Tirzepatide may help protect the kidneys in people with type 2 diabetes [6]. It helps slow down the decline of kidney function (eGFR) and prevents the growth of protein in the urine, called microalbuminuria. This helps people with chronic kidney disease or those at a high risk of heart disease.


Tirzepatide For Weight Loss


Weight Loss Clinic LA offers the best Tirzepatide for weight loss near me in Beverly Hills but can also come to your home or office throughout the Los Angeles area. We serve patients near Beverly Hills, Bel Air, West Hollywood, Santa Monica, West Los Angeles, Culver City, Hollywood, Venice, Marina del Rey, Malibu, Manhattan Beach, Redondo Beach, Downtown Los Angeles, Encino, Woodland Hills, Sherman Oaks, Calabasas, Burbank, Glendale, Hidden Hills, Agoura Hills, Northridge, North Hollywood, Topanga, Canoga Park, Reseda, Valley Glen, Chatsworth, West Hills, Winnetka, Universal City, Silverlake, Echo Park, and many more.


  1. Dubey, Anna. “tirzepatide”. Encyclopedia Britannica, 28 Jan. 2024, https://www.britannica.com/science/tirzepatide. Accessed 29 January 2024.
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine. 2022;387(3):205-216. doi:https://doi.org/10.1056/nejmoa2206038
  3. Dubey, Anna. “tirzepatide”. Encyclopedia Britannica, 28 Jan. 2024, https://www.britannica.com/science/tirzepatide. Accessed 29 January 2024.
  4. Azuri J, Hammerman A, Enis Aboalhasan, Sluckis B, Ronen Arbel. Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis. Diabetes, Obesity and Metabolism. 2022;25(4):961-964. doi:https://doi.org/10.1111/dom.14940
  5. Jastreboff AM, Aronne LJ, Ahmad N, et al. Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine. 2022;387(3):205-216. doi:https://doi.org/10.1056/nejmoa2206038
  6. Catalina Bosch, Sol Carriazo, María José Soler, Alberto Ortiz, Beatriz Fernandez-Fernandez, Tirzepatide and prevention of chronic kidney disease, Clinical Kidney Journal, Volume 16, Issue 5, June 2023, Pages 797–808, https://doi.org/10.1093/ckj/sfac274

Book Appointment

"*" indicates required fields

Step 1 of 3

*Please use ZIP code that matches your Credit Card otherwise it will be declined.
Our Staff will contact you to Confirm and Schedule time of Appointment